• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PSMA、TERT 和 PDEF 在前列腺恶性肿瘤中的临床意义。

Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.

机构信息

Department of Urology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou City, Guangdong Province, China.

出版信息

Eur Rev Med Pharmacol Sci. 2017 Aug;21(15):3347-3352.

PMID:28829509
Abstract

OBJECTIVE

To investigate the clinical significance of the expression of PSMA (prostate specific membrane antigen), TERT (telomerase reverse transcriptase), and PDEF (prostate derived Ets factor) in malignant tumors of the prostate.

PATIENTS AND METHODS

The study was conducted with paraffin slices from 33 specimens of malignant tumors of the prostate and 17 of normal tissue. We found high levels of PSMA, TERT, and PDEF protein by Western blot and immunofluorescence in the malignant tumor of the prostate. We also detected upregulation of PSMA, TERT, and PDEF mRNA in the malignant tumor of the prostate, suggesting complex regulation of these three genes in prostate cancer.

RESULTS

Variance analysis showed statistically significant differences comparing the expression of PSMA, TERT, and PDEF in the malignant tumor of the prostate and normal tissues. The high expression of PSMA, TERT, and PDEF in the malignant tumor of the prostate suggests the important roles of these three factors in the occurrence and development of the malignant tumors of the prostate.

CONCLUSIONS

PSMA, TERT, and PDEF may serve as a reference for clinical diagnosis and as potential targets for the malignant tumor of the prostate therapeutics.

摘要

目的

探讨 PSMA(前列腺特异膜抗原)、TERT(端粒酶逆转录酶)和 PDEF(前列腺衍生 Ets 因子)在前列腺恶性肿瘤中的表达的临床意义。

患者与方法

本研究采用 33 例前列腺恶性肿瘤标本和 17 例正常组织的石蜡切片进行研究。我们通过 Western blot 和免疫荧光法发现,前列腺恶性肿瘤中 PSMA、TERT 和 PDEF 蛋白水平升高。我们还检测到前列腺恶性肿瘤中 PSMA、TERT 和 PDEFmRNA 的上调,提示这三个基因在前列腺癌中存在复杂的调控。

结果

方差分析显示,前列腺恶性肿瘤与正常组织中 PSMA、TERT 和 PDEF 的表达存在统计学差异。前列腺恶性肿瘤中 PSMA、TERT 和 PDEF 的高表达提示这三个因素在前列腺恶性肿瘤的发生发展中具有重要作用。

结论

PSMA、TERT 和 PDEF 可作为临床诊断的参考指标,并可能成为前列腺恶性肿瘤治疗的潜在靶点。

相似文献

1
Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.PSMA、TERT 和 PDEF 在前列腺恶性肿瘤中的临床意义。
Eur Rev Med Pharmacol Sci. 2017 Aug;21(15):3347-3352.
2
High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.前列腺癌中PSM-E的高表达与肿瘤分级相关:一种新的前列腺特异性膜抗原可变剪接变体
Prostate. 2007 Dec 1;67(16):1791-800. doi: 10.1002/pros.20664.
3
Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.前列腺特异性膜抗原(PSMA)与一种前列腺特异性膜抗原样基因的比较分析
Prostate. 2004 Feb 1;58(2):200-10. doi: 10.1002/pros.10319.
4
Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.PDEF 的缺失与前列腺癌侵袭性表型有关:PDEF 对 MMP9 的调控。
Mol Cancer. 2010 Jun 15;9:148. doi: 10.1186/1476-4598-9-148.
5
Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.前列腺癌患者中前列腺特异性膜抗原及PSMA三种可变剪接变体的表达
Int J Cancer. 2003 Nov 1;107(2):323-9. doi: 10.1002/ijc.11402.
6
Signatures of prostate-derived Ets factor (PDEF) in cancer.前列腺源性Ets因子(PDEF)在癌症中的特征。
Tumour Biol. 2016 Nov;37(11):14335-14340. doi: 10.1007/s13277-016-5326-1. Epub 2016 Sep 10.
7
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.前列腺癌进展过程中 PDEF 蛋白表达缺失的机制及其功能后果。
Prostate. 2011 Dec;71(16):1723-35. doi: 10.1002/pros.21389. Epub 2011 Mar 28.
8
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.前列腺衍生的 Ets 转录因子 (PDEF) 是前列腺癌患者的潜在预后标志物。
Prostate. 2011 Aug 1;71(11):1178-88. doi: 10.1002/pros.21333. Epub 2011 Jan 12.
9
PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.PGC 和 PSMA 在前列腺癌诊断中的应用:活检样本的组织分析。
Int Braz J Urol. 2013 Sep-Oct;39(5):649-56. doi: 10.1590/S1677-5538.IBJU.2013.05.06.
10
Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.Ets 转录因子通过整合素 β3 介导的信号通路抑制肿瘤转移的功能。
J Cell Physiol. 2019 Nov;234(11):20266-20274. doi: 10.1002/jcp.28627. Epub 2019 Apr 14.

引用本文的文献

1
Upregulation of SPDEF is associated with poor prognosis in prostate cancer.SPDEF的上调与前列腺癌的不良预后相关。
Oncol Lett. 2019 Nov;18(5):5107-5118. doi: 10.3892/ol.2019.10885. Epub 2019 Sep 19.